Capital Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,565
| Closed | -$216K | – | 582 |
|
|
2022
Q3 | $216K | Sell |
6,565
-2,272
| -26% | -$74.8K | 0.01% | 483 |
|
|
2022
Q2 | $278K | Buy |
8,837
+411
| +5% | +$12.9K | 0.01% | 452 |
|
|
2022
Q1 | $387K | Buy |
8,426
+117
| +1% | +$5.37K | 0.01% | 408 |
|
|
2021
Q4 | $509K | Sell |
8,309
-2,090
| -20% | -$128K | 0.02% | 368 |
|
|
2021
Q3 | $777K | Sell |
10,399
-23
| -0.2% | -$1.72K | 0.03% | 306 |
|
|
2021
Q2 | $964K | Sell |
10,422
-6,294
| -38% | -$582K | 0.03% | 275 |
|
|
2021
Q1 | $1.48M | Buy |
16,716
+2,504
| +18% | +$222K | 0.06% | 204 |
|
|
2020
Q4 | $1.33M | Buy |
14,212
+7,412
| +109% | +$691K | 0.06% | 199 |
|
|
2020
Q3 | $433K | Buy |
+6,800
| New | +$433K | 0.02% | 335 |
|